» Articles » PMID: 28154375

Notch As a Tumour Suppressor

Overview
Journal Nat Rev Cancer
Specialty Oncology
Date 2017 Feb 4
PMID 28154375
Citations 184
Authors
Affiliations
Soon will be listed here.
Abstract

The Notch signalling cascade is an evolutionarily conserved pathway that has a crucial role in regulating development and homeostasis in various tissues. The cellular processes and events that it controls are diverse, and continued investigation over recent decades has revealed how the role of Notch signalling is multifaceted and highly context dependent. Consistent with the far-reaching impact that Notch has on development and homeostasis, aberrant activity of the pathway is also linked to the initiation and progression of several malignancies, and Notch can in fact be either oncogenic or tumour suppressive depending on the tissue and cellular context. The Notch pathway therefore represents an important target for therapeutic agents designed to treat many types of cancer. In this Review, we focus on the latest developments relating specifically to the tumour-suppressor activity of Notch signalling and discuss the potential mechanisms by which Notch can inhibit carcinogenesis in various tissues. Potential therapeutic strategies aimed at restoring or augmenting Notch-mediated tumour suppression will also be highlighted.

Citing Articles

Notch signaling in the tumor immune microenvironment of colorectal cancer: mechanisms and therapeutic opportunities.

Sun J, Chen Y, Xu Z, Wang W, Li P J Transl Med. 2025; 23(1):315.

PMID: 40075484 PMC: 11900264. DOI: 10.1186/s12967-025-06282-z.


Modes of Notch signalling in development and disease.

Bray S, Bigas A Nat Rev Mol Cell Biol. 2025; .

PMID: 40065190 DOI: 10.1038/s41580-025-00835-2.


The Role of Pentacyclic Triterpenoids in Non-Small Cell Lung Cancer: The Mechanisms of Action and Therapeutic Potential.

Lee Y, Kwon R, Lee H, Chung J, Kim Y, Jeong H Pharmaceutics. 2025; 17(1).

PMID: 39861671 PMC: 11768946. DOI: 10.3390/pharmaceutics17010022.


Chronic exposure to hexavalent chromium induces esophageal tumorigenesis via activating the Notch signaling pathway.

Zhu Y, Liu F, Liu L, Wang J, Gao F, Ye L J Zhejiang Univ Sci B. 2025; 26(1):76-91.

PMID: 39815612 PMC: 11735908. DOI: 10.1631/jzus.B2300896.


Molecular docking and analysis of the pharmacokinetics, toxicological profile and differential gene expression of bioactive compounds from .

Araujo N, da Silva Junior F, Santos L, Batistuzzo de Medeiros S, Felzenszwalb I, Araujo-Lima C Toxicol Rep. 2024; 13:101810.

PMID: 39629241 PMC: 11612344. DOI: 10.1016/j.toxrep.2024.101810.


References
1.
Kawaguchi K, Honda M, Yamashita T, Okada H, Shirasaki T, Nishikawa M . Jagged1 DNA Copy Number Variation Is Associated with Poor Outcome in Liver Cancer. Am J Pathol. 2016; 186(8):2055-2067. DOI: 10.1016/j.ajpath.2016.04.011. View

2.
Dill M, Rothweiler S, Djonov V, Hlushchuk R, Tornillo L, Terracciano L . Disruption of Notch1 induces vascular remodeling, intussusceptive angiogenesis, and angiosarcomas in livers of mice. Gastroenterology. 2012; 142(4):967-977.e2. DOI: 10.1053/j.gastro.2011.12.052. View

3.
Dotto G . Crosstalk of Notch with p53 and p63 in cancer growth control. Nat Rev Cancer. 2009; 9(8):587-95. PMC: 6059364. DOI: 10.1038/nrc2675. View

4.
Dumortier A, Durham A, Di Piazza M, Vauclair S, Koch U, Ferrand G . Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin. PLoS One. 2010; 5(2):e9258. PMC: 2823782. DOI: 10.1371/journal.pone.0009258. View

5.
Zeng Q, Li S, Chepeha D, Giordano T, Li J, Zhang H . Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell. 2005; 8(1):13-23. DOI: 10.1016/j.ccr.2005.06.004. View